OneMedNet Corporation (ONMD) Fair Value 2026

ONMD · Health Information Services ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

4.8 /10

32 fundamental signals · 1 models active

Value Trap Risk

LOW (33/100)

Quick Summary — As of 2026-08-28, OneMedNet Corporation (ONMD) trades at $0.58. QOC: 4.8/10. Value Trap Risk: 33/100 (LOW). 1/13 models active.

Key Facts

Ticker
ONMD
Price
$0.58
Quality Score
4.8/10
Value Trap Risk
33/100
Models Active
1/13
Last Updated
Strength: 1 independent models provide multi-angle coverage
Risk: Below-average Quality Score of 4.8/10 signals weak fundamentals

What Fair Value Does Each Model Give ONMD?

1 Intrinsic Value Models vs. Current Price ($0.58)

Core Models (Unlocked)
Model Fair Value Upside
Asset-Based · High Conviction
 $0.02 -96.0%

All Models Active

All 1 models are displayed above.

What Is OneMedNet Corporation (ONMD) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, OneMedNet Corporation's intrinsic value is estimated at $0.02. Trading at its current price of $0.58, the valuation engine raises significant caution: 1 of 1 models flag downside risk, projecting a median implied return of -96.0%.

What Do the Models Say About ONMD?

1 of 13 models are currently active for ONMD. All 1 active models suggest the stock trades above fair value. See which stocks rank higher →

How Does ONMD Rank in Health Information Services?

Among 55 Health Information Services stocks, ONMD ranks #46 by Quality of Company score. CirclFi's QOC score of 4.8/10 evaluates 32 fundamental signals. A score of 4.8 reflects mixed fundamentals.

See all Most Undervalued Health Information Services Stocks →

OneMedNet Corporation operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is ONMD a Value Trap?

CirclFi's Value Trap algorithm assigns ONMD a score of 33/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

1 of 13 models are active for OneMedNet Corporation. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, OneMedNet Corporation scores 4.8 out of 10 on our 32-signal quality assessment, a moderate rating that shows mixed signals across our quality framework with notable weaknesses. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every ONMD valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across ONMD's 1 active models, average confidence is 52%. Moderate confidence indicates reasonable fit.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy OneMedNet Corporation Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Health Information Services Stocks Should You Also Analyze?

11 related Health Information Services stocks with 13-model coverage

VSEEVSee Health, Inc.QOC 4.8BEATHeartBeam, Inc.QOC 4.7WORXSCWorx CorpQOC 4.8MSPRMSP Recovery, Inc.QOC 4.7MGRXMangoceuticals, Inc.QOC 4.8RVRCRevium Rx.QOC 4.5HSTMHealthStream, Inc.QOC 8.7TDOCTeladoc Health, Inc.QOC 7.3HTFLHeartflow, Inc.QOC 6.1DOCSDoximity, Inc.QOC 9.6HQYHealthEquity, Inc.QOC 9.5

Read investment analysis: VSEE · BEAT · WORX · MSPR · MGRX · RVRC · HSTM · TDOC · HTFL · DOCS · HQY

Which Other Stocks Have a Similar Quality Score to ONMD?

7 companies across all industries closest to ONMD’s Quality of Company score of 4.8/10.

CNSYCerenome, Inc.QOC 4.8TTRXTurn Therapeutics Inc.QOC 4.8OXSQOxford Square Capital Corp.QOC 4.8QNCXQuince Therapeutics, Inc.QOC 4.8GBUXGivBux, Inc.QOC 4.8TSATTelesat CorporationQOC 4.8NVDANVIDIA CorporationQOC 10.0

Read investment analysis: CNSY · TTRX · OXSQ · QNCX · GBUX · TSAT · NVDA

Where Does ONMD Sit in CirclFi's Health Information Services Rankings?

ONMD is ranked against every other Health Information Services stock CirclFi covers in each of these screens.

See all Health Information Services stocks ranked →

What Else Do Investors Ask About OneMedNet Corporation’s Valuation?

What is OneMedNet Corporation's intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for OneMedNet Corporation (ONMD). The Quality of Company score is 4.8/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is ONMD overvalued or undervalued right now?

At $0.58, 0 of 1 active models suggest ONMD may be undervalued, while 1 indicate potential overvaluation. The assessment depends on which methodology best fits OneMedNet Corporation's business model in Health Information Services.

What does a Quality of Company score of 4.8 mean for ONMD?

OneMedNet Corporation's QOC of 4.8/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on ONMD?

CirclFi analyzes ONMD with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 1 of 13 are active for this stock. Read the full methodology →

Is ONMD a value trap in 2026?

OneMedNet Corporation's Value Trap score is 33/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns OneMedNet Corporation (ONMD) a Quality of Company score of 4.8/10 across 32 fundamental signals as of 2026-08-28.” Source: circlfi.com/stock/ONMD/ · Methodology
Primary sources for this ONMD valuation
  • Financial statements: OneMedNet Corporation 10-K and 10-Q filings on SEC EDGAR (CIK 0001849380) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for ONMD as of ; valuations recomputed .